Seeking a more comprehensive understanding of sexual violence in Utah
Even a single instance of abuse is too many.
University of Utah professor Julie Valentine, a forensic nurse who created one of the world's best sexual assault archival databases, described how sexual assault often 'shatters people's worldviews,' echoing Israeli researchers who define rape as 'an act that denies an individual's humanity.'
This is why, on a question as important as sexual violence against children and adults, it's important to learn as much as we can from as many sources as we can. 'You can't make changes unless you can know and understand what's going on,' said Leslie Miles, a researcher on sexual violence and professor at BYU's College of Nursing.
When important data sources are missed, we may inadvertently reach inaccurate conclusions. For instance, over the past decade, claims have circulated suggesting there is an especially high risk of sexual violence for adolescent girls and adult women living in Utah compared with the rest of the country.
Many familiar with other data about the state have found this conclusion puzzling. When recently asked about allegations Utah was worse than other locations in terms of sexual violence, Professor Justin Dyer, who researches Utah youth, said, 'such a claim seems out of step with what we already know in this area.'
Taking into account all the data
Like other important questions about Utah, so much depends on which information and data is being seriously considered (and which is not). Kathleen C. Basile, associate director for Science in the Division of Violence Prevention in the Center for Injury Prevention and Control at the CDC, told the Deseret News, 'I think readers and those who are interested in this kind of (sexual violence) data should look at all the sources.'
Her colleague, Sharon G. Smith, also a behavioral scientist in the Division of Violence Prevention at the CDC, likewise said that 'using all of these data together helps give you a better picture of what the problem actually looks like.'
Utah researchers agree. Valentine said, 'you have to always look at all of the studies,' and ask yourself, 'where are they gathering this information?'
We have found three meaningful data sources that have frequently been overlooked in public discussions about sexual violence rates in Utah.
1. From crime figures to anonymous self-report
In the FBI's Crime Data Explorer, Utah in 2023 had 54.4 rapes reported to police per 100,000 inhabitants. Since there are only five states higher, numbers like this have frequently been compared with other states over the last decade.
Yet the FBI 'strongly discourages' these kinds of state-by-state comparisons based solely on their official crime statistics. With so many variable influences on both crime and willingness to report crime, higher and lower official figures cannot be simply taken at face value. Instead, we must also ask:
Could lower criminal justice numbers reflect gaps in how crimes are revealed, reported, or recorded, rather than a lower actual rate of violence in that area?
Are higher official figures potentially reflecting higher objective levels of violence or indications of a community that, for a variety of reasons, has found different ways to encourage more accountability and disclosure?
For example, after work in 2017 to 'create a climate where students will report,' BYU administrators were encouraged to see a rise in the number of students reporting sexual assaults — considering this 'a sign that more of them trust changes made by the school and are getting the help they need.'
It's this uncertainty around official crime figures that highlights the value of taking into account anonymous self-report measures that we've found offer a uniquely accurate glimpse into especially painful and sensitive experiences.
'If we want to truly understand the scope of who's affected by sexual assault, sexual abuse and rape, our most reliable (sources) are going to be the anonymous surveys,' Valentine said. 'Because for a host of reasons, rape and sexual assault is the number one crime that is not reported.'
This nationally recognized expert on rape continued, 'when you have these anonymous surveys, you know your numbers are going to be vastly different from if you're looking at FBI Uniform Crime Reports.'
To gather these more anonymous self-report numbers across states, the CDC conducted a National Intimate Partner and Sexual Violence Survey first in 2012, then in 2016/2017. Tragically, over half all women in the United States reported some sexual violence (with over 67 million victims estimated nationally).
Because this survey of 10,000 American adults carefully samples representative people in each state, its comparisons across locations are more valid. In state-by-state comparisons, Utah had the lowest lifetime prevalence of sexual assault for any state, with approximately 37% of Utah women surveyed reporting an experience with sexual assault at some point in their life. This was six points lower than the next lowest state of Texas (43%) and 17 points lower than the national average (54%).
When asked why this figure was so different from other available crime data, CDC researcher Kathleen Basile pointed again to the limitations in reported FBI data. 'Most survivors or victims don't always think of their experiences as crimes,' she explained, 'particularly sexual violence and intimate partner violence, where usually the victim and perpetrator know each other well.'
That's why, Basile said 'if you frame the questioning and the measurement in a crime context, you will get less reporting and less disclosure.' By contrast, she believes the fact the National Intimate Partner and Sexual Violence survey frames questions as a health survey means 'you get more disclosure, more reporting and higher prevalence.'
Basile also said anonymity is another reason 'why there's more disclosure in these types of surveys.'
Yet data obtained in other anonymous surveys remains complex. Another self-report survey run by the CDC, the Behavioral Risk Factor Surveillance System, gathers data on sexual-related 'adverse childhood experiences' (ACEs). By this metric, 15.5% of Utah adults in the 2020 survey and 14.3% of Utah adults from 2018, 2020 and 2022 surveys combined, recall some kind of experience of sexual abuse in their upbringing (both higher than the 12.6% national average, with states ranging between 8.6 and 18%).
This comparison, however, is complicated by the fact that states reported data anywhere from 2011 to 2020 — limiting the quality of state-by-state comparisons, since Utah's own ACEs data 'changed significantly' over the years due to 'changes in openness to reporting childhood adversity.'
That's why Utah's Public Health Indicator Based Information System refers to this dataset with a caution that 'comparing data from different years across the country might not be the best approach.'
2. From statewide to community-specific
While generalized, statewide numbers for Utah get frequent attention, more specific analyses can raise new insights. For instance, if membership in The Church of Jesus Christ of Latter-day Saints made someone more vulnerable to sexual assault, we would expect to see elevated rates of sexual violence in more Latter-day Saint heavy areas, all other things being equal.
That's opposite of what available comparative data across Utah's population centers suggests.
While FBI data shouldn't be used as a definitive, stand-alone tool for comparing states, it may still offer useful insights when examining patterns within a single state or region.
In Utah, for instance, the rate of reported rape per 100,000 inhabitants in the more Latter-day Saint-heavy Provo/Utah/Orem metropolitan area is 40.8 per 100,000 people, lower than the Utah average. The Salt Lake City/Murray area is 65.3, the Ogden area is 48.7, and the St. George Metropolitan area is 44.3.
This data suggests that more Latter-day Saint-heavy metropolitan areas have lower rates of sexual violence in Utah.
In a similar way, if there is something about membership in The Church of Jesus Christ of Latter-day Saints that prevents sexual assault, we would expect to see lower rates of sexual assaults at the Church's universities, compared with other campuses.
That's precisely what we find when we look at the latest 2023 data gathered by the U.S. Department of Education on sexual assault on American campuses. Brigham Young University-Provo reports .03 rapes per thousand students, while the University of Utah reports 4.96 per thousand students, and Utah Valley University and Utah State report .07 and .11, respectively. Looking outside of Utah, UCLA reports 1.54, while the University of Nevada in Las Vegas is .19.
3. From umbrella statistics to more precise measures
One widely cited finding from the 2021 CDC Youth Risk Behavior Survey is that 21.4% of Utah teenage girls surveyed reported having 'experienced sexual violence by anyone' in the past year, which was 3.5 points higher than the 17.9% of teenage girls who report some kind of sexual violence in the U.S. as a whole.
Like the Utah ACEs data, this YRBS data was administered in fall of 2021 when the pandemic effects were lingering. With more high schoolers learning remotely these years, the sample may be skewed toward those physically present, since remote or at-home administrations didn't occur. The fact that this gap between Utah and the national average reflected in the 2021 survey was sharply reduced after COVID (Utah 17.7,% U.S. 17% in 2023) seems to confirm a potential influence.
A research team led by John J. Santelli at Columbia University has also flagged a higher level of missing data in the 2021 CDC survey — with 29.5% of students with missing data on sexual questions in 2019, compared with 7% in 2011. Due to what they call a 'crisis in participation,' Santelli's team highlight the 'possibility of bias' in this survey's estimates of adolescent behavior and 'raise serious concerns about the validity of trends' identified by this study.
They go so far as to state openly that 'the 2021 YRBS data should not be used by researchers to estimate changes in sexual experience and other adolescent behaviors in comparison to prior survey years without appropriate age adjustments or explanations.'
Even if the 2021 CDC numbers are accurate, it's also the case that the concerning statistic in question is uniquely broad, bringing together under one umbrella a wide range of unwanted behaviors: touching, kissing and intercourse.
Clearly, any form of an unwanted romantic or sexual overture is a significant problem. But when this same 2021 analysis tightened the focus to asking specifically about 'sexual dating violence' and 'forced sexual intercourse,' Utah was in both cases lower than the national average in 2021 (and has been for most of the other years measuring each of these variables).
None of this is to argue that everything is OK in the state. Like elsewhere in the country, Utah continues to grapple with the growing consequences of sexualization online and its real-life impacts.
The University of Utah's Julie Valentine is leading a case review analysis to understand more about the increase in strangulation taking place during sexual violence (with choking a frequent theme of modern online pornography). And the Utah's Commission on Criminal & Juvenile Justice's updated 2024 figures confirm a 97% increase between 2022 and 2024 when it comes to prison admissions for sex offenses in the state.
Better data, more improvement
Utah State professor, Susan Madsen, has spent a decade exploring ways to further elevate women and girls in Utah, culminating in the ambitious 'Bolder Way Forward' initiative. In an interview for this Deseret News in-depth series on sexual violence in Utah, she described her efforts to 'pull in every piece of data in our reports.'
With so much data out there, Madsen expressed appreciation for the scope of this broader investigation into prevalence numbers. 'Thank you for digging in as deep as you have.'
When significant problems have been identified in Utah, real change takes place. For instance, a 2016 analysis by Valentine found only 61.8% of rape kits being submitted by law enforcement to the state crime lab for testing. Legislation was passed the next year ensuring that close to 100% of rape kits move along to testing, according to Valentine.
That kind of swift systemic improvement arose directly from Valentine and her colleagues' more comprehensive look at available forensic data between 2010 and 2022. Her team is currently facing barriers in creating a similar database for sexually abused children in the state, which she says could 'really have a huge impact in the field.'
One nonprofit that monitors reform in this area now calls Utah a 'Model of Bipartisan Cooperation on Rape Kit Reform' and reports on their website that 'Utah has achieved all six pillars of rape kit reform.'
Better data, more unity
A deeper appreciation of data could invite broader unity in fighting abuse — one that recognizes variable rates of sexual violence are inherently complex, influenced by a wide array of different, interacting vulnerabilities.
Liliana Olvera-Arbon, executive director of Utah Coalition Against Sexual Assault, emphasizes the importance of holding onto the 'hope that we can eliminate sexual violence. I do believe that.'
But in order to do that, she added, everyone in the community — not just 'one entity' — will need to work together as a more unified 'collective.'
'We don't want to blame,' cautions BYU professor Leslie Miles. When her team finds something law enforcement can improve in a particular county, they work individually with that police department in a productive way.
'The only ones that have any blame are the perpetrators,' she added. Once research highlights a concerning pattern, her focus becomes: 'How can we do this better?'
'If we're not doing something right as a public or as mental health or as medical providers,' she adds, 'then just tell us what we're doing, and then let's come up with a plan to improve.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Here's How This Forgotten Healthcare Stock Could Generate Life-Changing Returns
Key Points CRISPR Therapeutics' first approved therapy, Casgevy, was a breakthrough. One of Casgevy's biggest achievements may be demonstrating the viability of CRISPR Therapeutics' strategy. The biotech company could soar if it can follow up that win with more clinical and regulatory milestones. 10 stocks we like better than CRISPR Therapeutics › Over the past few years, the market hasn't been kind to somewhat speculative, unprofitable stocks. CRISPR Therapeutics (NASDAQ: CRSP), a mid-cap biotech, fits that description. The company's shares are down by 24% since mid-2022. The S&P 500 is up 50% over the same period. Despite this terrible performance, there are reasons to believe that CRISPR Therapeutics could still generate life-changing returns for investors willing to be patient. Here's how the biotech could pull it off. CRISPR Therapeutics' first success CRISPR Therapeutics' first approval was for Casgevy, a treatment for sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT), which it developed in collaboration with Vertex Pharmaceuticals. Before Casgevy, no CRISPR-based gene-editing medicine had been approved. While it became the first, it still faces some challenges. Ex vivo gene-editing therapies require a complex manufacturing and administration process that can only be performed in authorized treatment centers (ATCs). Moreover, they're expensive. Casgevy costs $2.2 million in the U.S. Getting third-party payers on board for that is no easy feat. Still, CRISPR Therapeutics and Vertex Pharmaceuticals are making steady progress. As of the second quarter, CRISPR Therapeutics had achieved its goal of activating 75 ATCs. It had also secured reimbursement for eligible patients in 10 countries. The two companies estimate there are roughly 60,000 eligible SCD and TDT patients in the regions they have targeted. Let's say they continue to strike reimbursement deals and can count on third-party coverage for 70% of this target population (42,000 people), then go on to treat another 30% of that group in the next decade (12,600 patients). Assuming they could extend that $2.2 million price tag to those countries, Casgevy could generate more than $27.7 billion over this period. Based on its agreement with Vertex, 40% would go to CRISPR Therapeutics, or roughly $11.1 billion over a decade. That's not bad, but it's not that impressive either. So, while Casgevy could contribute meaningfully to CRISPR Therapeutics' results -- and may even reach blockbuster status at some point -- the medicine may primarily serve as a proof of concept to demonstrate that the biotech's approach can be effective. Substantial progress with its first commercialized product will help the stock price. But the company's performance will depend even more on future clinical and regulatory milestones, especially as it shows with Casgevy that it can manage the intricacies and complexities of marketing gene-editing medicines. Can the pipeline deliver? CRISPR Therapeutics has six candidates in clinical trials, which isn't bad at all for a mid-cap biotech company. One of its leading programs is CTX310, a potential therapy designed to help reduce low-density lipoprotein (LDL) cholesterol in patients with certain conditions. CTX310 is already producing encouraging clinical trial results. Additionally, it's an in vivo medicine, meaning it bypasses the need to harvest patients' cells to manufacture therapies; in vivo gene-editing treatments are easier to handle than their ex vivo counterparts. The company's path to creating life-changing returns hinges on its ability to deliver consistent clinical and regulatory wins over the next few years for CTX310 and other important candidates. If CRISPR Therapeutics can successfully launch several new products in the next five to seven years, its shares are likely to skyrocket. In the meantime, under this scenario, the company would succeed in making gene-editing medicines more mainstream. This would encourage third-party payers to get on board -- and healthcare institutions, and perhaps even governments, to help push for more ATCs, since there'd be a greater need to accommodate these treatments. Can CRISPR Therapeutics achieve this? In my view, the biotech stock is on the riskier side, but does carry significant upside potential. There's a (small) chance the gene-editing specialist will deliver life-changing returns in the next decade, but investors need to hedge their bets. It's best to start by initiating a small position in the stock, then progressively add more if CRISPR Therapeutics lands more wins. Should you invest $1,000 in CRISPR Therapeutics right now? Before you buy stock in CRISPR Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and CRISPR Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Prosper Junior Bakiny has positions in Vertex Pharmaceuticals. The Motley Fool has positions in and recommends CRISPR Therapeutics and Vertex Pharmaceuticals. The Motley Fool has a disclosure policy. Here's How This Forgotten Healthcare Stock Could Generate Life-Changing Returns was originally published by The Motley Fool
Yahoo
5 hours ago
- Yahoo
It's been a long road, but Blood Oxygen tracking is back for the newest Apple Watches in the US – but the feature isn't the same
When you buy through links on our articles, Future and its syndication partners may earn a commission. Following an 18-month ban, Blood Oxygen tracking is coming back to the Apple Watch Series 9, Series 10, and Ultra 2 It's not an entirely on-device experience anymore, though The Apple Watch still measures Blood Oxygen, but the iPhone will calculate and display the final result It's been a long 18 months, but Apple's announced that Blood Oxygen tracking and monitoring are returning to the Apple Watch Series 9, Series 10, and Ultra 2 in the United States. The feature was disabled and effectively banned on the Series 9 and Ultra 2 – then the Series 10, which launched later – after a ruling in January 2024 due to a patent dispute over the technology being used between Massimo and Apple. Now, thanks to iOS 18.6.1 and watchOS 11.6.1, which will roll out later today, the feature is returning in a 'redesigned' form. In its new iteration, the Apple Watch Series 9, Series 10, and Ultra 2's sensors can take a reading, then transmit the data to the connected iPhone, where it will be calculated and displayed in the Health app under 'Respiratory' readings. So no, you won't be able to take the reading, watch as it progresses, and then view the results right on your wrist, as you could before. Still, this does effectively return the tracking and monitoring functionality to the impacted Apple Watch models in the United States. In a statement shared, Apple explains the changes as: 'Users with these models in the U.S. who currently do not have the Blood Oxygen feature will have access to the redesigned Blood Oxygen feature by updating their paired iPhone to iOS 18.6.1, and their Apple Watch to watchOS 11.6.1. Following this update, sensor data from the Blood Oxygen app on Apple Watch will be measured and calculated on the paired iPhone, and results can be viewed in the Respiratory section of the Health app. This update was enabled by a recent U.S. Customs ruling.' The U.S. Customs ruling is key here, as this will return the feature to the Apple Watches sold when the ban began and was subsequently enforced. If you still have an older Apple Watch, or one sold prior to January 2024, the Blood Oxygen functionality remains unimpacted and won't be changed. That also goes for any models sold outside of the United States, which have been unimpacted by this ruling. Still, this does return the Blood Oxygen feature to the Apple Watch, even if it splits the experience between watch and phone. But this separation is likely key to having this allowed and approved by U.S. Customs. For those who have purchased an Apple Watch Series 9, 10, or Ultra 2 in those many months, this is a return to form and rounding out of the health tracking features on Apple's star wearable in the United States. Even in our Apple Watch Series 10 review, we noted that the Blood Oxygen tracking feature was missing in the US. Apple has a pretty smart rollout here, and considering rumors of further pushes into health features that we might see with future generations of Apple Watch models, it might be helpful to have these readings going straight into the Health app. Either route, though, if you've been waiting for Blood Oxygen tracking to return, it's back, but you'll want to make sure your iPhone is nearby if you want to see the results. While Apple has not shared an exact timing for the rollouts of iOS 18.6.1 and watchOS 11.6.1, it has promised to arrive today – August 14, 2025 – in the United States, and we'll update this piece when we see it rolling out. You might also like Constantly dismissing notifications on your Apple Watch? You're going to love Apple's watchOS 26 latest gesture I'm a fitness tracker expert, and here are my top 3 subscription-free picks for 2025 Garmin Venu X1 review: The most innovative Garmin watch in years, and a genuine Apple Watch Ultra rival
Yahoo
6 hours ago
- Yahoo
High-potency cannabis use linked to psychosis
More research is showing that the use of high-potency cannabis may elevate the risk of dissociation, including schizophrenia. Nivrita Ganguly speaks with Dr. Leslie Buckley, Chief of Addictions at the Centre for Addiction and Mental Health (CAMH) about what is known and not known about the link between cannabis and psychosis.